BioCentury
ARTICLE | Clinical News

CMV gB/MF59: Phase II data

March 23, 2009 7:00 AM UTC

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) published data in the New England Journal of Medicine showing that treatment with CMV gB/MF59 resulted in a significa...